Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

10 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Gain-of-Function Chromatin Remodeling Activity of Oncogenic FOXL2-C134W Reprograms Glucocorticoid Receptor Occupancy to Drive Granulosa Cell Tumors.
Welte T, Vuttaradhi VK, Khlebus EY, Brodsky A, Flores Legarreta A, Celestino J, Powell RT, Stephan CC, Nguyen N, Li J, Takamatsu S, Calzoncinth K, Sood AK, Gershenson DM, Futreal PA, Lawson B, Hillman RT. Welte T, et al. Among authors: flores legarreta a. Cancer Res. 2024 Dec 9. doi: 10.1158/0008-5472.CAN-24-2341. Online ahead of print. Cancer Res. 2024. PMID: 39652611
TERT promoter mutations and survival outcomes in adult-type granulosa cell tumors.
Brodsky AL, Flores Legarreta A, Fellman BM, Glassman D, How J, Vuttaradhi V, Sood AK, Ramondetta LM, Gershenson D, Hillman RT. Brodsky AL, et al. Among authors: flores legarreta a. Int J Gynecol Cancer. 2025 Jan 6:ijgc-2024-005837. doi: 10.1136/ijgc-2024-005837. Online ahead of print. Int J Gynecol Cancer. 2025. PMID: 39395821
Neuroendocrine neoplasms of the ovary: a review of 63 cases.
Flores Legarreta A, Saab R, Gonzales NR, Chisholm GB, Westin SN, Hillman RT, Frumovitz M. Flores Legarreta A, et al. Int J Gynecol Cancer. 2024 Apr 1;34(4):566-573. doi: 10.1136/ijgc-2023-005063. Int J Gynecol Cancer. 2024. PMID: 38290783 Review.
Impact of pelvic radiation therapy in patients with early neuroendocrine cervical carcinoma and no residual disease in the radical hysterectomy specimen: a NeCTuR study.
Khurana N, Frumovitz M, Flores Legarreta A, Ramalingam P, Jhingran A, Bhosale P, Saab R, Gonzales NRR, Chisholm GB, Salvo G. Khurana N, et al. Among authors: flores legarreta a. Int J Gynecol Cancer. 2024 Feb 5;34(2):209-215. doi: 10.1136/ijgc-2023-005053. Int J Gynecol Cancer. 2024. PMID: 38101814
Clinical outcomes of leuprolide acetate in the treatment of recurrent ovarian granulosa cell tumors.
Foster KI, Flores Legarreta A, Kamat R, Handley KF, Glassman D, How JA, Lawson BC, Westin SN, Ramondetta LM, Frumovitz M, Gershenson DM, Sood AK, Hillman RT. Foster KI, et al. Among authors: flores legarreta a. Am J Obstet Gynecol. 2023 Jun;228(6):724.e1-724.e9. doi: 10.1016/j.ajog.2023.02.029. Epub 2023 Mar 11. Am J Obstet Gynecol. 2023. PMID: 36907533 Free PMC article.
Combination therapy with topotecan, paclitaxel, and bevacizumab improves progression-free survival in patients with recurrent high-grade neuroendocrine cervical cancer: a Neuroendocrine Cervical Tumor Registry (NeCTuR) study.
Frumovitz M, Chisholm GB, Jhingran A, Ramalingam P, Flores-Legarreta A, Bhosale P, Gonzales NR, Hillman RT, Salvo G. Frumovitz M, et al. Among authors: flores legarreta a. Am J Obstet Gynecol. 2023 Apr;228(4):445.e1-445.e8. doi: 10.1016/j.ajog.2022.12.009. Epub 2022 Dec 11. Am J Obstet Gynecol. 2023. PMID: 36516952